Charles Ronsin

Nephrologist

[Maine-Anjou AAV-GN Research Group @MaineAnjouReg]

Results of the open label TAPIR trial: glucocorticoid discontinuation in GPA #ANCA vasculitis.
▶️ higher number of relapse at 6 months for the discontinuation group
▶️ but driven by minor relapses and by subgroup not treated but Rituximab. @DrPeterMerkel #vasculitisBCN2024

[Maine-Anjou AAV-GN Research Group @MaineAnjouReg]

Post-hoc PEXIVAS analysis: no effect of reduced GC dose on kidney recovery. Faster kidney recovery with PLEX but no sustained effect beyond 3 months.
1️⃣ real PLEX effect vs convection effect?
2️⃣ how about stratification by histological class? @odlerb #vasculitisBCN2024

[KIReports @KIReports]

Clinical Presentation, Pathological Spectrum, and Outcomes of #Alcoholic #Cirrhosis-Related IgA Nephropathy #IgAN

#VisualAbstract by @DrPSVali

https://t.co/WdMC3igxsY

[IMMUNOV @FondsImmunov]

Bravo à la team @FondsImmunov qui a couru ce matin le semi-marathon de Paris pour la recherche sur les maladies auto-immunes et inflammatoires !!
Maintenant c’est à vous, vos dons sont essentiels 👉 https://t.co/Ry9pU5d7aY
Merci pour votre soutien 🙏

[nature @Nature]

Why are women so much more susceptible to autoimmune diseases than men?

A new explanation for the discrepancy has emerged https://t.co/vMwDyNxzmF

[ACR_Journals @ACR_Journals]

Somatic mutations in UBA1 cause VEXAS, a severe inflammatory syndrome. For the first time, researchers have found 74 people with the mutation who don't have VEXAS. Studying them may give a peek into the earliest phases of disease.

In A&R
https://t.co/vrknbiYBMK
@rheumrob

[Maine-Anjou AAV-GN Research Group @MaineAnjouReg]

Maintenance of AAV by RTX, based on B cell repop or serological flare (ANCA rise), after receiving at least 2 years treatment with RTX: more relapses in the ANCA rise group. ie: wait longer for treatment = more relapses. No placebo control group though. https://t.co/OeIBU211Zv

[Kidney International @Kidney_Int]

Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH)

https://t.co/ZxU9QthyLK

@IcahnMountSinai @MountSinaiLiver @ISMMSKidney
#CKD #fibrosis #transcriptomes #lipidomics

[Isnard Pierre @IsnardPierre1]

Congratulations to @glomwhisperer (Thibaut d'Izarny-Gargas) and JP Duong for this fascinating work which highlights the renal vasculature as a target during MPN-associated vasculopathy. Thanks to all contributors!
https://t.co/lyQcW1upPX

[Katalin Susztak @KSusztak]

Daratumumab ( anti CD38 Ab) monotherapy for refractory lupus nephritis | ⁦@NatureMedicine⁩ https://t.co/taaJvT2lXf

[Charles Ronsin @RonsinCharles]

@com_SFNDT @LucileFigueres @c_massoumipour

[SFNDT @com_SFNDT]

Une enquête menée par une équipe de Nantes s'intéresse aux habitudes des néphrologues concernant leurs prises en charge.
Vous êtes néphrologue et vous souhaitez participer ? C'est ici: https://t.co/w1OAAIrlhW

[SFNDT @com_SFNDT]

[Participation Enquête]
L’infection des kystes rénaux est une complication classique des patients ayant une polykystose rénale autosomique dominante. Pourtant, peu de données sont publiées à ce sujet…

[Charles Ronsin @RonsinCharles]

@TERPays2LaLoire Le train a destination du croisic a 8h05 ter858057 est maintenu ?

[CKJ @CKJsocial]

🆕CD44 – parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome
📖https://t.co/ydlpgm7dA4👈